TPH2 and fatty liver disease: In HFD-fed mice, genetic deletion of adipocyte-specific TPH2 reduced both adipose and circulating levels of 5-HT, adipose depot weights, and improved glucose homeostasis and hepatic steatosis, while increasing systemic EE and intestinal energy-harvesting efficiency.